Literature DB >> 26273930

Frequency and Severity of Adverse Drug Events by Medication Classes: The JADE Study.

Mio Sakuma, Yuko Kanemoto1, Akari Furuse1, David W Bates, Takeshi Morimoto2.   

Abstract

OBJECTIVE: Adverse drug events (ADEs) are a significant concern in daily practice; however, the profile of high-risk drugs remains unclear. Our objective was to categorize high-risk medication classes according to frequency and severity of ADEs.
METHODS: The JADE study is a prospective cohort study of 3459 hospitalized adult patients. We investigated the ADEs and medications prescribed to the patients. The rate of ADEs for each medication class was calculated by dividing the number of ADEs by the number of patients who received each medication class on admission.
RESULTS: Overall, 14,435 medications were ordered on admission for patients (median 4; interquartile range, 2-6). Electrolytes and fluids were most frequently prescribed (1876 patients, 54%). Sedatives, antibiotics, peptic ulcer drugs, and analgesics were also commonly prescribed. The frequency was similar in both elderly and younger patients. Among 1010 identified ADEs, antibiotics were most frequently associated with ADEs (31 ADEs per 100 prescribed patients on admission). In patients 65 years and older, corticosteroids, anticonvulsants, laxatives, nonsteroidal anti-inflammatory drugs, and antipsychotics were the 5 most frequent medication classes causing ADEs following antibiotics. In patients younger than 65 years, antibiotics were also the most frequent cause of ADEs, followed by laxatives, lipid-lowering agents, anticonvulsants, and corticosteroids. Among cardiovascular agent-associated ADEs, 46% were fatal or life threatening in elderly patients, whereas antihypertensives were most often associated with fatal or life-threatening ADEs (25%) in younger patients.
CONCLUSIONS: The medication classes frequently associated with ADEs did not necessarily induce severe ADEs.

Entities:  

Mesh:

Year:  2020        PMID: 26273930     DOI: 10.1097/PTS.0000000000000235

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.844


  3 in total

Review 1.  High-risk medication in community care: a scoping review.

Authors:  Irina Dumitrescu; Minne Casteels; Kristel De Vliegher; Tinne Dilles
Journal:  Eur J Clin Pharmacol       Date:  2020-02-05       Impact factor: 2.953

2.  Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).

Authors:  Niccolò Lombardi; Giada Crescioli; Alessandra Bettiol; Marco Tuccori; Annalisa Capuano; Roberto Bonaiuti; Alessandro Mugelli; Mauro Venegoni; Giuseppe Danilo Vighi; Alfredo Vannacci
Journal:  Front Pharmacol       Date:  2020-04-06       Impact factor: 5.810

3.  Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan Adverse Drug Events Study.

Authors:  Hiroki Murayama; Mio Sakuma; Yuri Takahashi; Takeshi Morimoto
Journal:  Pharmacol Res Perspect       Date:  2018-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.